Antidepressant use, depression, and survival in patients with heart failure. 2008

Christopher M O'Connor, and Wei Jiang, and Maragatha Kuchibhatla, and Rajendra H Mehta, and Greg L Clary, and Michael S Cuffe, and Eric J Christopher, and Jude D Alexander, and Robert M Califf, and Ranga R Krishnan
Department of Medicine, Duke Clinical Research Institute, Duke University Medical Center, 2400 N Pratt St, Box 3356, Durham, NC 27705, USA. oconn002@mc.duke.edu

BACKGROUND Recent studies suggest that the use of antidepressants may be associated with increased mortality in patients with cardiac disease. Because depression has also been shown to be associated with increased mortality in these patients, it remains unclear if this association is attributable to the use of antidepressants or to depression. METHODS To evaluate the association of long-term mortality with antidepressant use and depression, we studied 1006 patients aged 18 years or older with clinical heart failure and an ejection fraction of 35% or less (62% with ischemic disease) between March 1997 and June 2003. The patients were followed up for vital status annually thereafter. Depression status, which was assessed by the Beck Depression Inventory (BDI) scale and use of antidepressants, was prospectively collected. The main outcome of interest was long-term mortality. RESULTS Of the study patients, 30.0% were depressed (defined by a BDI score > or =10) and 24.2% were taking antidepressants (79.6% of these patients were taking selective serotonin reuptake inhibitors [SSRIs] only). The vital status was obtained from all participants at an average follow-up of 972 (731) (mean [SD]) days. During this period, 42.7% of the participants died. Overall, the use of antidepressants (unadjusted hazard ratio [HR], 1.32; 95% confidence interval [CI], 1.03-1.69) or SSRIs only (unadjusted HR, 1.32; 95% CI, 0.99-1.74) was associated with increased mortality. However, the association between antidepressant use (HR, 1.24; 95% CI, 0.94-1.64) and increased mortality no longer existed after depression and other confounders were controlled for. Nonetheless, depression remained associated with increased mortality (HR, 1.33; 95% CI, 1.07-1.66). Similarly, depression (HR, 1.34; 95% CI, 1.08-1.68) rather than SSRI use (HR, 1.10; 95% CI, 0.81-1.50) was independently associated with increased mortality after adjustment. CONCLUSIONS Our findings suggest that depression (defined by a BDI score > or =10), but not antidepressant use, is associated with increased mortality in patients with heart failure.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003863 Depression Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders. Depressive Symptoms,Emotional Depression,Depression, Emotional,Depressive Symptom,Symptom, Depressive
D005260 Female Females
D006333 Heart Failure A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. Cardiac Failure,Heart Decompensation,Congestive Heart Failure,Heart Failure, Congestive,Heart Failure, Left-Sided,Heart Failure, Right-Sided,Left-Sided Heart Failure,Myocardial Failure,Right-Sided Heart Failure,Decompensation, Heart,Heart Failure, Left Sided,Heart Failure, Right Sided,Left Sided Heart Failure,Right Sided Heart Failure
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000928 Antidepressive Agents Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. Antidepressant,Antidepressant Drug,Antidepressant Medication,Antidepressants,Antidepressive Agent,Thymoanaleptic,Thymoanaleptics,Thymoleptic,Thymoleptics,Antidepressant Drugs,Agent, Antidepressive,Drug, Antidepressant,Medication, Antidepressant
D000929 Antidepressive Agents, Tricyclic Substances that contain a fused three-ring moiety and are used in the treatment of depression. These drugs block the uptake of norepinephrine and serotonin into axon terminals and may block some subtypes of serotonin, adrenergic, and histamine receptors. However, the mechanism of their antidepressant effects is not clear because the therapeutic effects usually take weeks to develop and may reflect compensatory changes in the central nervous system. Antidepressants, Tricyclic,Tricyclic Antidepressant,Tricyclic Antidepressant Drug,Tricyclic Antidepressive Agent,Tricyclic Antidepressive Agents,Antidepressant Drugs, Tricyclic,Agent, Tricyclic Antidepressive,Agents, Tricyclic Antidepressive,Antidepressant Drug, Tricyclic,Antidepressant, Tricyclic,Antidepressive Agent, Tricyclic,Drug, Tricyclic Antidepressant,Drugs, Tricyclic Antidepressant,Tricyclic Antidepressant Drugs,Tricyclic Antidepressants
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor

Related Publications

Christopher M O'Connor, and Wei Jiang, and Maragatha Kuchibhatla, and Rajendra H Mehta, and Greg L Clary, and Michael S Cuffe, and Eric J Christopher, and Jude D Alexander, and Robert M Califf, and Ranga R Krishnan
April 2016, International journal of cardiology,
Christopher M O'Connor, and Wei Jiang, and Maragatha Kuchibhatla, and Rajendra H Mehta, and Greg L Clary, and Michael S Cuffe, and Eric J Christopher, and Jude D Alexander, and Robert M Califf, and Ranga R Krishnan
January 2020, General hospital psychiatry,
Christopher M O'Connor, and Wei Jiang, and Maragatha Kuchibhatla, and Rajendra H Mehta, and Greg L Clary, and Michael S Cuffe, and Eric J Christopher, and Jude D Alexander, and Robert M Califf, and Ranga R Krishnan
January 2012, International journal of psychiatry in medicine,
Christopher M O'Connor, and Wei Jiang, and Maragatha Kuchibhatla, and Rajendra H Mehta, and Greg L Clary, and Michael S Cuffe, and Eric J Christopher, and Jude D Alexander, and Robert M Califf, and Ranga R Krishnan
February 2008, Patient preference and adherence,
Christopher M O'Connor, and Wei Jiang, and Maragatha Kuchibhatla, and Rajendra H Mehta, and Greg L Clary, and Michael S Cuffe, and Eric J Christopher, and Jude D Alexander, and Robert M Califf, and Ranga R Krishnan
January 2016, International journal of cardiology,
Christopher M O'Connor, and Wei Jiang, and Maragatha Kuchibhatla, and Rajendra H Mehta, and Greg L Clary, and Michael S Cuffe, and Eric J Christopher, and Jude D Alexander, and Robert M Califf, and Ranga R Krishnan
October 2016, Psychosomatic medicine,
Christopher M O'Connor, and Wei Jiang, and Maragatha Kuchibhatla, and Rajendra H Mehta, and Greg L Clary, and Michael S Cuffe, and Eric J Christopher, and Jude D Alexander, and Robert M Califf, and Ranga R Krishnan
January 2005, Archives of internal medicine,
Christopher M O'Connor, and Wei Jiang, and Maragatha Kuchibhatla, and Rajendra H Mehta, and Greg L Clary, and Michael S Cuffe, and Eric J Christopher, and Jude D Alexander, and Robert M Califf, and Ranga R Krishnan
February 2005, Journal of cardiac failure,
Christopher M O'Connor, and Wei Jiang, and Maragatha Kuchibhatla, and Rajendra H Mehta, and Greg L Clary, and Michael S Cuffe, and Eric J Christopher, and Jude D Alexander, and Robert M Califf, and Ranga R Krishnan
November 2017, Circulation. Heart failure,
Christopher M O'Connor, and Wei Jiang, and Maragatha Kuchibhatla, and Rajendra H Mehta, and Greg L Clary, and Michael S Cuffe, and Eric J Christopher, and Jude D Alexander, and Robert M Califf, and Ranga R Krishnan
January 2006, L'Encephale,
Copied contents to your clipboard!